Weighted Change-Point Method for Detecting Differential Gene Expression in Breast Cancer Microarray Data

In previous work, we proposed a method for detecting differential gene expression based on change-point of expression profile. This non-parametric change-point method gave promising result in both simulation study and public dataset experiment. However, the performance is still limited by the less sensitiveness to the right bound and the statistical significance of the statistics has not been fully explored. To overcome the insensitiveness to the right bound we modified the original method by adding a weight function to the Dn statistic. Simulation study showed that the weighted change-point statistics method is significantly better than the original NPCPS in terms of ROC, false positive rate, as well as change-point estimate. The mean absolute error of the estimated change-point by weighted change-point method was 0.03, reduced by more than 50% comparing with the original 0.06, and the mean FPR was reduced by more than 55%. Experiment on microarray Dataset I resulted in 3974 differentially expressed genes out of total 5293 genes; experiment on microarray Dataset II resulted in 9983 differentially expressed genes among total 12576 genes. In summary, the method proposed here is an effective modification to the previous method especially when only a small subset of cancer samples has DGE.

[1]  T. Jiang,et al.  Confirmation by exome sequencing of the pathogenic role of NCSTN mutations in acne inversa (hidradenitis suppurativa). , 2011, The Journal of investigative dermatology.

[2]  K. Savage,et al.  The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma. , 2005, Blood.

[3]  Wei Pan,et al.  A mixture model approach to detecting differentially expressed genes with microarray data , 2003, Functional & Integrative Genomics.

[4]  Chong Xing,et al.  Mean, median and tri-mean based statistical detection methods for differential gene expression in microarray data , 2010, 2010 3rd International Congress on Image and Signal Processing.

[5]  R. Brent,et al.  Genomic Biology , 2000, Cell.

[6]  E. Seto,et al.  Histone deacetylases and cancer , 2007, Oncogene.

[7]  W. Isaacs,et al.  A novel role of myosin VI in human prostate cancer. , 2006, The American journal of pathology.

[8]  Yao Wang,et al.  Tri-mean-based statistical differential gene expression detection , 2012, Int. J. Data Min. Bioinform..

[9]  John D. Storey,et al.  SAM Thresholding and False Discovery Rates for Detecting Differential Gene Expression in DNA Microarrays , 2003 .

[10]  Michael J. Becich,et al.  Tests for finding complex patterns of differential expression in cancers: towards individualized medicine , 2004, BMC Bioinformatics.

[11]  D. Powe,et al.  Heterotrimeric G protein signaling in cancer cells with regard to metastasis formation , 2011, Cell cycle.

[12]  M. Daha,et al.  Immunoglobulin D enhances the release of tumour necrosis factor‐α, and interleukin‐1β as well as interleukin‐1 receptor antagonist from human mononuclear cells , 1996, Immunology.

[13]  Baolin Wu,et al.  Cancer outlier differential gene expression detection. , 2007, Biostatistics.

[14]  Chen-Yang Shen,et al.  The clinical implications of MMP-11 and CK-20 expression in human breast cancer. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[15]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[16]  T. Tomonaga,et al.  Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy. , 2005, Cancer research.

[17]  Y. Tian,et al.  Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells , 2010, Cell Death and Differentiation.

[18]  M. Waterman,et al.  Diversity of LEF/TCF action in development and disease , 2006, Oncogene.

[19]  A. Pardee,et al.  Analysing differential gene expression in cancer , 2003, Nature Reviews Cancer.

[20]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Jianhua Hu,et al.  Cancer outlier detection based on likelihood ratio test , 2008, Bioinform..

[22]  M. Miettinen.  Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors. , 1987, Archives of pathology & laboratory medicine.

[23]  Nonparametric Statistical Inference for Distribution Change Point Problems , 2000 .

[24]  Josef Jiricny,et al.  The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis , 2009, Molecular Cancer.

[25]  R. Tibshirani,et al.  Outlier sums for differential gene expression analysis. , 2007, Biostatistics.

[26]  Chenying Zhang,et al.  High-throughput cell-based screening reveals a role for ZNF131 as a repressor of ERalpha signaling , 2008, BMC Genomics.

[27]  Andrew J. Bannister,et al.  The putative tumour suppressor Fus-2 is an N-acetyltransferase , 2000, Oncogene.

[28]  John D. Storey,et al.  Empirical Bayes Analysis of a Microarray Experiment , 2001 .

[29]  R. Matusik,et al.  Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model , 2010, The Prostate.

[30]  Y. Yamashita,et al.  Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis—critical role in tumor invasion , 2010, International journal of cancer.

[31]  G. Watkins,et al.  Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance. , 2008, Journal of experimental therapeutics & oncology.

[32]  X. Jin,et al.  Expression of anion exchanger 2 in human gastric cancer. , 2008, Experimental oncology.

[33]  K. Ravichandran,et al.  Regulation of Arf6 and ACAP1 Signaling by the PTB-Domain-Containing Adaptor Protein GULP , 2007, Current Biology.

[34]  J. Tchinda,et al.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.

[35]  M. Raffeld,et al.  Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues , 2000, Modern Pathology.

[36]  H. Lian.  MOST: detecting cancer differential gene expression. , 2007, Biostatistics.

[37]  T. Liloglou,et al.  Methylation discriminators in NSCLC identified by a microarray based approach. , 2005, International journal of oncology.

[38]  R. Spang,et al.  Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Loh,et al.  Upregulation of plasma C9 protein in gastric cancer patients , 2010, Proteomics.

[40]  P. Sebastiani,et al.  Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile , 2010, British Journal of Cancer.

[41]  M. Davis,et al.  UNC119 is required for G protein trafficking in sensory neurons , 2011, Nature Neuroscience.

[42]  H. Vogel,et al.  Breast cancer brain metastases express the sodium iodide symporter , 2010, Journal of Neuro-Oncology.

[43]  M. Kazanietz,et al.  Protein kinase C and other diacylglycerol effectors in cancer , 2007, Nature Reviews Cancer.

[44]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[45]  Yanchun Liang,et al.  Non-Parametric Change-Point Method for Differential Gene Expression Detection , 2011, PloS one.

[46]  Debashis Ghosh,et al.  COPA - cancer outlier profile analysis , 2006, Bioinform..

[47]  Dae‐Ghon Kim,et al.  Over‐expression of the ribosomal protein L36a gene is associated with cellular proliferation in hepatocellular carcinoma , 2004, Hepatology.

[48]  M. Yaniv,et al.  SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. , 2005, Cancer research.

[49]  E. Olson,et al.  Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  N. Plesnila,et al.  Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. , 2008, Cell metabolism.

[51]  Carolyn J. Brown,et al.  The functional role of long non-coding RNA in human carcinomas , 2011, Molecular Cancer.

[52]  H. Yokozaki,et al.  Expression of receptors for advanced glycation end‐products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer , 2002, The Journal of pathology.

[53]  Y. Onodera,et al.  Requirement for Arf6 in breast cancer invasive activities. , 2004, Proceedings of the National Academy of Sciences of the United States of America.